{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:43:21Z","timestamp":1791261801200,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":654,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-6849"],"award-info":[{"award-number":["MOP-6849"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-GM72688"],"award-info":[{"award-number":["R01-GM72688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-CA132700"],"award-info":[{"award-number":["R21-CA132700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM07281"],"award-info":[{"award-number":["T32GM07281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RR-15301"],"award-info":[{"award-number":["RR-15301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ASTF 293.00-2009"],"award-info":[{"award-number":["ASTF 293.00-2009"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.cell.2011.08.046","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T15:01:37Z","timestamp":1318863697000},"page":"306-319","source":"Crossref","is-referenced-by-count":136,"title":["Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis"],"prefix":"10.1016","volume":"147","author":[{"given":"Florian","family":"Grebien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hantschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Kaupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz\u00a0M.","family":"Wyrzucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald\u00a0D.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Beug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Pawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2011.08.046_bib1","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.93.10.4604","article-title":"Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins","volume":"93","author":"Belshaw","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2011.08.046_bib2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.08.046_bib3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/leu.2008.242","article-title":"Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases","volume":"22","author":"De Keersmaecker","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2011.08.046_bib4","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.08.046_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2008.07.047","article-title":"Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation","volume":"134","author":"Filippakopoulos","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.sbi.2009.10.001","article-title":"SH2 domains: modulators of nonreceptor tyrosine kinase activity","volume":"19","author":"Filippakopoulos","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1280","article-title":"Regulation of the c-Abl and Bcr-Abl tyrosine kinases","volume":"5","author":"Hantschel","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0092-8674(03)00191-0","article-title":"A myristoyl\/phosphotyrosine switch regulates c-Abl","volume":"112","author":"Hantschel","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molonc.2008.07.003","article-title":"The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia","volume":"2","author":"Hantschel","year":"2008","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cell.2011.08.046_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2011.08.046_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.cell.2011.08.046_bib12","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897","article-title":"The SH2 domain of P210BCR\/ABL is not required for the transformation of hematopoietic factor-dependent cells","volume":"86","author":"Ilaria","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.08.046_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/leu.2009.193","article-title":"Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history","volume":"24","author":"Jabbour","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2011.08.046_bib14","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/bi700127c","article-title":"A remote substrate docking mechanism for the tec family tyrosine kinases","volume":"46","author":"Joseph","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.cell.2011.08.046_bib15","first-page":"95","article-title":"Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain","volume":"352","author":"Koide","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0960-9822(95)00060-1","article-title":"Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases","volume":"5","author":"Mayer","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib17","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1128\/MCB.13.12.7587","article-title":"A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins","volume":"13","author":"McWhirter","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jmb.2010.04.045","article-title":"Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk","volume":"399","author":"Mikkola","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","article-title":"The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase","volume":"96","author":"Million","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.08.046_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(03)00194-6","article-title":"Structural basis for the autoinhibition of c-Abl tyrosine kinase","volume":"112","author":"Nagar","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.molcel.2006.01.035","article-title":"Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase","volume":"21","author":"Nagar","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator\u00a0of transcription (STAT)5 activation by BCR\/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR\/ABL and is required for leukemogenesis","volume":"189","author":"Nieborowska-Skorska","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2011.08.046_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0962-8924(01)02154-7","article-title":"SH2 domains, interaction modules and cellular wiring","volume":"11","author":"Pawson","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib24","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cell.2011.08.046_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the\u00a0radar: the new wave of BCR-ABL inhibitors","volume":"6","author":"Quint\u00e1s-Cardama","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2011.08.046_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2011.08.046_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood.V97.1.4","article-title":"The src homology 2 domain of Bcr\/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase","volume":"97","author":"Roumiantsev","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.08.046_bib28","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/MCB.6.12.4396","article-title":"A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps","volume":"6","author":"Sadowski","year":"1986","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","article-title":"Critical role for Gab2 in transformation by BCR\/ABL","volume":"1","author":"Sattler","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.08.046_bib31","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/sj.onc.1206942","article-title":"Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias","volume":"22","author":"Shah","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2011.08.046_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2008.11.001","article-title":"Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis","volume":"14","author":"Shah","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2011.08.046_bib33","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood-2008-10-183665","article-title":"BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib","volume":"116","author":"Sherbenou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cell.2011.08.046_bib34","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1074\/jbc.M801337200","article-title":"Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib\/nilotinib and dasatinib","volume":"283","author":"Vajpai","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.08.046_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nsmb.1793","article-title":"A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain","volume":"17","author":"Wojcik","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2011.08.046_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back","volume":"22","author":"Wong","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2011.08.046_bib37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2011.08.046_bib38","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763.","DOI":"10.1107\/S0907444994003112"},{"key":"10.1016\/j.cell.2011.08.046_bib39","doi-asserted-by":"crossref","unstructured":"Baril\u00e1, D., and Superti-Furga, G. (1998). An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18, 280\u2013282.","DOI":"10.1038\/ng0398-280"},{"key":"10.1016\/j.cell.2011.08.046_bib40","doi-asserted-by":"crossref","unstructured":"Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., Murray, L.W., Arendall, W.B., 3rd, Snoeyink, J., Richardson, J.S., and Richardson, D.C. (2007). MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35 (Web Server issue), W375\u2013W383.","DOI":"10.1093\/nar\/gkm216"},{"key":"10.1016\/j.cell.2011.08.046_bib41","unstructured":"DeLano, W.L. (2002). The PyMOL Molecular Graphics System. http:\/\/pymol.sourceforge.net."},{"key":"10.1016\/j.cell.2011.08.046_bib42","doi-asserted-by":"crossref","unstructured":"Filippakopoulos, P., Kofler, M., Hantschel, O., Gish, G.D., Grebien, F., Salah, E., Neudecker, P., Kay, L.E., Turk, B.E., Superti-Furga, G., et\u00a0al. (2008). Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134, 793\u2013803.","DOI":"10.1016\/j.cell.2008.07.047"},{"key":"10.1016\/j.cell.2011.08.046_bib43","doi-asserted-by":"crossref","unstructured":"Garrard, S.M., Longenecker, K.L., Lewis, M.E., Sheffield, P.J., and Derewenda, Z.S. (2001). Expression, purification, and crystallization of the RGS-like domain from the Rho nucleotide exchange factor, PDZ-RhoGEF, using the surface entropy reduction approach. Protein Expr. Purif. 21, 412\u2013416.","DOI":"10.1006\/prep.2001.1392"},{"key":"10.1016\/j.cell.2011.08.046_bib44","doi-asserted-by":"crossref","unstructured":"Koide, A., Gilbreth, R.N., Esaki, K., Tereshko, V., and Koide, S. (2007). High-affinity single-domain binding proteins with a binary-code interface. Proc. Natl. Acad. Sci. USA 104, 6632\u20136637.","DOI":"10.1073\/pnas.0700149104"},{"key":"10.1016\/j.cell.2011.08.046_bib45","doi-asserted-by":"crossref","unstructured":"Kunkel, T.A., Bebenek, K., and McClary, J. (1991). Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204, 125\u2013139.","DOI":"10.1016\/0076-6879(91)04008-C"},{"key":"10.1016\/j.cell.2011.08.046_bib46","doi-asserted-by":"crossref","unstructured":"Lawrence, M.S., Phillips, K.J., and Liu, D.R. (2007). Supercharging proteins can impart unusual resilience. J. Am. Chem. Soc. 129, 10110\u201310112.","DOI":"10.1021\/ja071641y"},{"key":"10.1016\/j.cell.2011.08.046_bib47","doi-asserted-by":"crossref","unstructured":"Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326.","DOI":"10.1016\/S0076-6879(97)76066-X"},{"key":"10.1016\/j.cell.2011.08.046_bib48","doi-asserted-by":"crossref","unstructured":"Painter, J., and Merritt, E.A. (2006). Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62, 439\u2013450.","DOI":"10.1107\/S0907444906005270"},{"key":"10.1016\/j.cell.2011.08.046_bib49","doi-asserted-by":"crossref","unstructured":"Potterton, E., Briggs, P., Turkenburg, M., and Dodson, E. (2003). A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59, 1131\u20131137.","DOI":"10.1107\/S0907444903008126"},{"key":"10.1016\/j.cell.2011.08.046_bib50","doi-asserted-by":"crossref","unstructured":"Reynolds, C., Damerell, D., and Jones, S. (2009). ProtorP: a protein-protein interaction analysis server. Bioinformatics 25, 413\u2013414.","DOI":"10.1093\/bioinformatics\/btn584"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411010671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411010671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T23:24:51Z","timestamp":1593127491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867411010671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0092867411010671"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2011.08.046","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13357244.14726605","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}